Cas No.: | 1044871-04-6 |
Chemical Name: | 2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one |
Synonyms: | RVX297 |
Formula: | C24H29N3O4 |
M.Wt: | 423.513 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | RVX-297 is a novel orally active, BD2 selective, BET bromodomain inhibitor with Alpha Screen IC50 of 0.08, 0.05 and 0.02 uM for BRD2 (BD2), BRD3 (BD2) and BRD4 (BD2), respectively; displays about 50-fold selectivity over BD1; suppresses inflammatory gene expression in multiple immune cell types in culture; reduces pro-inflammatory mediators assessed in splenic gene expression and serum proteins in LPS model of inflammation. |